Status | Study |
Terminated |
Study Name: Initial Treatment of Patients With Immune Thrombocytopenic Purpura Condition: Immune Thrombocytopenic Purpura Date: 2009-10-07 Interventions: Drug: Dexamethasone USP Micronized |
Recruiting |
Study Name: Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) Condition: Thrombotic Thrombocytopenic Purpura Date: 2009-08-04 Interventions: Drug: Danazol Danazol 600 mg PO will be initiated with plasma exchange and corticosteroids at the time o |
Completed |
Study Name: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2008-06-25 Interventions: Drug: Fostamatinib Disodium / R935788 R935788 tablets |
Completed |
Study Name: Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation Condition: Immune Thrombocytopenic Purpura Date: 2008-02-12 Interventions: Drug: LGD-4665 LGD-4665 Thromb |
Completed |
Study Name: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2007-02-27 Interventions: Drug: Placebo Placebo Tablets |
Completed |
Study Name: ADAMTS13 in Thrombotic Thrombocytopenic Purpura Condition: Thrombotic Thrombocytopenic Purpura Date: 2007-01-24 |
Completed |
Study Name: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2006-09-06 Interventions: Drug: Rituximab 375mg/m2 per w |
Withdrawn |
Study Name: Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura Condition: Thrombotic Thrombocytopenic Purpura Date: 2005-11-07 Interventions: Drug: Rituximab Rituximab will be administered immediately after pheresis to minimize the amount of Ritu |
Terminated |
Study Name: Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) Condition: Idiopathic Thrombocytopenic Purpura Date: 2005-10-25 Interventions: Biological: GMA161 0.1 mg/kg, |
Terminated |
Study Name: Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy Condition: Autoimmune Thrombocytopenic Purpura Date: 2005-09-20 Interventions: Drug: Mabthéra |